跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确提出因果目标参数,并以目标最大似然估计评价自适应实验设计。

反馈分类问题

An Online Meta-Level Adaptive Design Framework with Targeted Learning Inference: Applications to Evaluating and Utilizing Surrogate Outcomes in Adaptive Designs

结合目标学习推断的在线元层级自适应设计框架

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Wenxin Zhang
Aaron Hudson
Maya Petersen
Mark van der Laan

结合目标学习推断的在线元层级自适应设计框架

研究问题
当多个自适应实验设计各有收益与成本时,如何在线评估并选择设计,尤其衡量不同替代结局对长期结局实验的作用?
方法与思路
作者定义用于评价自适应设计的因果目标参数,提出目标最大似然估计量,并将该框架用于选择由不同替代结局引导的设计。
材料陈述的贡献
摘要称估计量可容纳自适应数据的依赖并具有渐近正态性,框架能量化替代结局对异质效应检测、分配更新及参与者结局的作用。
阅读关注点
应核对设计评价参数的因果含义、未实施设计如何被识别,以及自适应依赖下推断与实时设计选择所需的条件。
阅读边界
仅据所给 OpenAlex 版本摘要;未说明识别、随机化概率和在线选择的具体条件,不能将非参数表述理解为无须假设或推断刊本变化。

原文摘要

Adaptive designs are increasingly used in clinical trials and online experiments to improve participant outcomes by dynamically updating treatment allocation as data accumulate. In practice, experimenters often consider multiple candidate designs, each with distinct trade-offs. However, typically only one design is implemented at a time, leaving benefits and costs of alternative designs unobserved and unquantified. To address this, we propose a novel meta-level adaptive design framework that enables real-time, data-driven evaluation and selection among candidate adaptive designs. Specifically, we define a new class of causal estimands to evaluate adaptive designs and propose Targeted Maximum Likelihood Estimators for these estimands. These estimators are asymptotically normal while accommodating dependence in adaptive-design data without parametric assumptions, enabling online selection among candidate designs. We further apply this framework to a motivating example where multiple surrogates of a long-term outcome are considered for updating randomization probabilities in adaptive experiments. Unlike existing surrogate evaluation methods, our approach comprehensively quantifies surrogates’ utility to accelerate detection of heterogeneous treatment effects, expedite updates to treatment randomization, and improve participant outcomes, facilitating dynamic selection among surrogate-guided designs. Overall, our framework provides a unified approach for evaluating opportunities and costs of various adaptive designs and guiding real-time decision-making in adaptive experiments.

笔记与分组